Increase the Lithium Dose
A serum lithium level of 0.3 mmol/L on 450 mg is subtherapeutic and requires dose escalation to achieve the minimum effective therapeutic range of 0.6-0.8 mmol/L for maintenance treatment of bipolar disorder 1, 2, 3, 4.
Rationale for Dose Increase
The current level of 0.3 mmol/L falls well below the established therapeutic range. The FDA label explicitly warns that lithium toxicity occurs close to therapeutic levels, emphasizing the critical importance of maintaining appropriate serum concentrations 1. However, being subtherapeutic poses its own significant risk—inadequate mood stabilization leading to relapse.
The evidence strongly supports maintaining levels between 0.6-0.8 mmol/L for optimal prophylaxis, with the landmark 1989 New England Journal of Medicine study demonstrating that patients maintained at 0.8-1.0 mmol/L had a 2.6 times lower relapse risk compared to those at 0.4-0.6 mmol/L 2. More recent evidence suggests the minimum efficacious level is 0.4 mmol/L, with optimal response at 0.6-0.75 mmol/L 4.
Specific Action Steps
Increase the lithium dose incrementally by 150-300 mg daily (to 600-750 mg total daily dose), depending on patient age and renal function 3
Recheck serum lithium level in 5-7 days after the dose adjustment to assess response, as steady-state is achieved in approximately 5 half-lives (5-7 days) 3
Ensure proper timing of blood draw: If using once-daily dosing, measure the level at 24 hours post-dose, not 12 hours, as 12-hour levels will be artificially elevated by approximately 1.3 times 5
Critical Pitfalls to Avoid
Do not accept 0.3 mmol/L as adequate: This level provides insufficient protection against mood episodes and increases relapse risk substantially 2, 4
Avoid abrupt large increases: Gradual dose escalation prevents overshooting into toxic range (>1.2 mmol/L), as the therapeutic window is narrow 1
Do not reduce monitoring frequency prematurely: Continue weekly monitoring until stable therapeutic levels are achieved, then transition to every 3 months 3
Watch for compliance issues: A level this low may indicate non-adherence rather than true pharmacokinetic resistance—verify the patient is actually taking the medication before escalating doses
Special Considerations
If the patient is elderly (>65 years), the dose increment should be more conservative (150 mg increases), though the same therapeutic range applies unless tolerability issues emerge 3, 6. The usual maintenance dose for adults under 40 is 925-1300 mg daily, suggesting significant room for dose escalation from the current 450 mg 3.